152 related articles for article (PubMed ID: 37541863)
1. Kidney Transplant Recipient With Tumefactive Demyelinating Lesions: A Case Report and Literature Review.
Mu L; Wang M; Cheng L; Liu P; Wang K
Transplant Proc; 2023 Oct; 55(8):1906-1909. PubMed ID: 37541863
[TBL] [Abstract][Full Text] [Related]
2. Liver Transplant Recipient With Tumefactive Demyelinating Lesions: A Case Report and Literature Review.
Wan DL; Ren KW; Zhang LL; Wang B; Zhai ZL; Zhang XY; Yang YC; Zheng SS
Transplant Proc; 2016 Nov; 48(9):3197-3202. PubMed ID: 27932180
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.
Cha S; Pierce S; Knopp EA; Johnson G; Yang C; Ton A; Litt AW; Zagzag D
AJNR Am J Neuroradiol; 2001; 22(6):1109-16. PubMed ID: 11415906
[TBL] [Abstract][Full Text] [Related]
4. Tumefactive demyelinating lesions: nine cases and a review of the literature.
Xia L; Lin S; Wang ZC; Li SW; Xu L; Wu J; Hao SY; Gao CC
Neurosurg Rev; 2009 Apr; 32(2):171-9; discussion 179. PubMed ID: 19172322
[TBL] [Abstract][Full Text] [Related]
5. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions.
Zhang Y; Zhang T; Zhang X; Yan X; Lei J; Liu R; Yang Y; Zhang C; Zhang J; Zhang Y; Yue W
Sci Rep; 2023 May; 13(1):7773. PubMed ID: 37179394
[TBL] [Abstract][Full Text] [Related]
7. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.
Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM
J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721
[TBL] [Abstract][Full Text] [Related]
8. Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma.
Sun C; Han J; Lin Y; Qi X; Li C; Liu J; Qiu F
Front Immunol; 2022; 13():986473. PubMed ID: 36059526
[TBL] [Abstract][Full Text] [Related]
9. Tumefactive demyelinating lesion: experience with two unusual patients.
Sinha MK; Garg RK; Bhatt ML; Chandra A
J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
[TBL] [Abstract][Full Text] [Related]
10. Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Jeong IH; Kim SH; Hyun JW; Joung A; Cho HJ; Kim HJ
J Neurol Sci; 2015 Nov; 358(1-2):118-24. PubMed ID: 26333950
[TBL] [Abstract][Full Text] [Related]
11. Tumefactive demyelinating lesions of 15 patients: Clinico-radiological features, management and review of the literature.
Sánchez P; Meca-Lallana V; Barbosa A; Manzanares R; Palmí I; Vivancos J
J Neurol Sci; 2017 Oct; 381():32-38. PubMed ID: 28991707
[TBL] [Abstract][Full Text] [Related]
12. Proton MR spectroscopy of tumefactive demyelinating lesions.
Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
[TBL] [Abstract][Full Text] [Related]
13. Silent Tumefactive Demyelinating Lesions and Radiologically Isolated Syndrome.
Ekmekci O; Eraslan C
Case Rep Neurol Med; 2018; 2018():8409247. PubMed ID: 30622825
[TBL] [Abstract][Full Text] [Related]
14. Tumour-like lesions in multiple sclerosis.
Jamroz-Wiśniewska A; Janczarek M; Belniak E; Stelmasiak Z; Bartosik-Psujek H
Neurol Neurochir Pol; 2008; 42(2):161-7. PubMed ID: 18512174
[TBL] [Abstract][Full Text] [Related]
15. A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia: doubtful CT, MRI, and bioptic findings: Case report and literature review.
Conforti R; Capasso R; Galasso R; Cirillo M; Taglialatela G; Galasso L
Medicine (Baltimore); 2016 Sep; 95(36):e4585. PubMed ID: 27603348
[TBL] [Abstract][Full Text] [Related]
16. Tumefactive demyelinating lesions: A comprehensive review.
Algahtani H; Shirah B; Alassiri A
Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
[TBL] [Abstract][Full Text] [Related]
17. Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
Lu SS; Kim SJ; Kim N; Kim HS; Choi CG; Lim YM
AJR Am J Roentgenol; 2015 Apr; 204(4):827-34. PubMed ID: 25794073
[TBL] [Abstract][Full Text] [Related]
18. A case of pediatric tumefactive demyelinating lesion misdiagnosed and treated as glioblastoma.
Riva D; Chiapparini L; Pollo B; Balestrini MR; Massimino M; Milani N
J Child Neurol; 2008 Aug; 23(8):944-7. PubMed ID: 18344459
[TBL] [Abstract][Full Text] [Related]
19. Tumefactive Demyelinating Lesions in Children: A Rare Case of Conus Medullaris Involvement and Systematic Review of the Literature.
Pérez CA; Patnaik A; Oommen S; Redko A; Mathis SB
J Child Neurol; 2020 Sep; 35(10):690-699. PubMed ID: 32552343
[TBL] [Abstract][Full Text] [Related]
20. Cerebral tumefactive demyelinating lesions.
Qi W; Jia GE; Wang X; Zhang M; Ma Z
Oncol Lett; 2015 Sep; 10(3):1763-1768. PubMed ID: 26622747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
